We are live on ! Find out more
Swiss National Bank

Swiss National Bank Portfolio holdings

AUM $191B
1-Year Est. Return 45.21%
 

The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.

This Fund
S&P 500
This Quarter Est. Return
+3.81%
1 Year Est. Return
+45.21%
3 Year Est. Return
+136.44%
5 Year Est. Return
+183.49%
10 Year Est. Return
+678.03%
AUM
$54.5B
AUM Growth
+$13.2B
Cap. Flow
+$13.6B
Cap. Flow %
25.01%
Top 10 Hldgs %
15.29%
Holding
2,649
New
6
Increased
2,585
Reduced
13
Closed
38

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$411M
2
MSFT icon
Microsoft
MSFT
+$309M
3
XOM icon
ExxonMobil
XOM
+$258M
4
JNJ icon
Johnson & Johnson
JNJ
+$221M
5
GE icon
GE Aerospace
GE
+$217M

Sector Composition

Rank Sector Weight
1 Technology 14.83%
2 Healthcare 14.67%
3 Consumer Discretionary 10.51%
4 Consumer Staples 10.31%
5 Industrials 10.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GLBL
2551
DELISTED
TerraForm Global, Inc. Class A Common Stock
GLBL
$209K ﹤0.01%
90,432
+39,732
+78% +$138K
FCEL icon
2552
FuelCell Energy
FCEL
$1.56B
$208K ﹤0.01%
89
+18
+25% +$37.6K
SRRA
2553
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$206K ﹤0.01%
788
+145
+23% +$46.3K
TTPH
2554
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$206K ﹤0.01%
2,310
+445
+24% +$44.4K
LQDT icon
2555
Liquidity Services
LQDT
$1.28B
$205K ﹤0.01%
40,950
+8,350
+26% +$44.6K
HHS icon
2556
Harte-Hanks
HHS
$18.5M
$204K ﹤0.01%
8,330
+1,390
+20% +$42.7K
BOJA
2557
DELISTED
Bojangles', Inc. Common Stock
BOJA
$201K ﹤0.01%
12,300
+2,900
+31% +$44.5K
SZYM
2558
DELISTED
SOLAZYME INC COM STK (DE)
SZYM
$201K ﹤0.01%
102,300
+18,500
+22% +$33K
OPY icon
2559
Oppenheimer Holdings
OPY
$1.21B
$197K ﹤0.01%
13,000
+3,100
+31% +$46.2K
LCTX icon
2560
Lineage Cell Therapeutics
LCTX
$278M
$191K ﹤0.01%
79,553
+14,629
+23% +$32.6K
GBT
2561
DELISTED
Global Blood Therapeutics, Inc.
GBT
$190K ﹤0.01%
12,500
+2,900
+30% +$51.5K
AEGR
2562
DELISTED
Aegerion Pharmaceuticals
AEGR
$188K ﹤0.01%
52,300
+8,400
+19% +$52K
AGFS
2563
DELISTED
AgroFresh Solutions Inc
AGFS
$187K ﹤0.01%
30,500
+6,900
+29% +$37.5K
DGICA icon
2564
Donegal Group Class A
DGICA
$695M
$186K ﹤0.01%
13,500
+3,100
+30% +$44.1K
CTIC
2565
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$185K ﹤0.01%
36,015
+10,665
+42% +$85.2K
MOBL
2566
DELISTED
MobileIron, Inc.
MOBL
$184K ﹤0.01%
42,500
+9,800
+30% +$36.6K
TVRD
2567
Tvardi Therapeutics
TVRD
$22.6M
$182K ﹤0.01%
836
+139
+20% +$41.5K
IIP
2568
DELISTED
INTERNAP NETWORK SERVICES CORPORATION
IIP
$180K ﹤0.01%
68,400
+13,700
+25% +$36.1K
USLM icon
2569
United States Lime & Minerals
USLM
$3.45B
$178K ﹤0.01%
15,500
+3,500
+29% +$37.9K
EVH icon
2570
Evolent Health
EVH
$481M
$175K ﹤0.01%
17,300
+4,200
+32% +$43.4K
RUN icon
2571
Sunrun
RUN
$2.4B
$174K ﹤0.01%
27,950
+6,750
+32% +$48.5K
OSIR
2572
DELISTED
Osiris Therapeutics, Inc. Common Stock
OSIR
$174K ﹤0.01%
31,500
+5,800
+23% +$40.5K
TCS
2573
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
$172K ﹤0.01%
2,023
+430
+27% +$34K
SRSC
2574
DELISTED
SEARS Canada Inc.
SRSC
$172K ﹤0.01%
62,900
+12,500
+25% +$41.3K
FMSA
2575
DELISTED
Fairmount Santrol Holdings Inc.
FMSA
$172K ﹤0.01%
70,900
+12,300
+21% +$26.3K

Similar funds

Swiss National Bank's Q1 2016 Portfolio in Review

As of Q1 2016, Swiss National Bank held 2,649 positions worth $54.5B, up 32% from $41.3B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Swiss National Bank deployed $13.6B of net new capital in Q1 2016, opening 6 new positions and adding to 2,585 existing holdings. Its largest new stake was Ferrari: 823,472 shares worth $32.9M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Stellantis, an estimated $25.2M trimmed.

  • Swiss National Bank's largest Q1 2016 buy was Ferrari: 823,472 shares worth $32.9M.
  • Swiss National Bank added most to Apple in Q1 2016, an estimated $411M increase.
  • Swiss National Bank's biggest Q1 2016 reduction was Stellantis, cutting an estimated $25.2M.
  • Swiss National Bank fully exited BROADCOM CORP CL-A in Q1 2016, selling an estimated $58.7M.
  • Swiss National Bank's ten largest holdings make up 15% of its $54.5B portfolio in Q1 2016.
  • Swiss National Bank opened 6 new positions and closed 38 in Q1 2016.
  • Swiss National Bank's portfolio value rose 32% quarter-over-quarter to $54.5B.

Based on Swiss National Bank's 13F filing for Q1 2016, filed 4 May 2016.